Skip to content

Clinical trials

Body Weight Changes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Body Weight Changes Country / region: United States Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20047
20053
20063
20074
20083
20095
20103
20113
20124
20131
20145
20152
20164
201711
20187
20197
20203
20218
20227
20236
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Recruiting8
Terminated8
Unknown status6
Withdrawn4
Active, not recruiting4
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pennington Biomedical Research Center5
Wake Forest University Health Sciences4
Washington University School of Medicine4
Brigham and Women's Hospital3
Case Comprehensive Cancer Center3
University of Colorado, Denver3
Duke University2
Kaiser Permanente2
Mayo Clinic2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Body Weight Changes110
Obesity49
Weight Loss25
Body Weight20
Overweight19
Breast Neoplasms9
Pediatric Obesity7
Anorexia4
Cachexia4
Diabetes Mellitus4

Trials

Showing 26 to 50 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.